Upcoming webinar: Speech as a biomarker in Ataxia: What can it tell us & how should we use it?


E2di2R_XMAA02Cl.jpgRedenlab CSO, Adam Vogel, will be presenting at the upcoming joint webinar with the European Reference Network for rare or low prevalence complex diseases, Neurological Diseases (ERN-RND), Neuromuscular Dieseases (ERN EURO-NMD), and European Academy of Neurology. The subject of the webinar is Speech as a biomarker in Ataxia: What can it tell us & how should we use it. Sign up here!

Related Post

Repetition Assessment for Speech and Language Disorders: A Study of the Logopenic Variant of Primary Progressive Aphasia

  • Posted on 10 March, 2023
    Primary Progressive Aphasia is a type of young onset dementia that is characterised by language impairment. Measuring disease progression and...
    Read more

    Adults with a history of recreational cannabis use have altered speech production

    • Posted on 10 March, 2023
      Stereotypical depictions of speech in cannabis users often suggest slow, laboured output, yet objective evidence supporting this assumption is extremely...
      Read more

      Perceptual and Acoustic Analysis of Speech in Spinocerebellar ataxia Type 1

      • Posted on 10 March, 2023
        Speech is a cardinal and important feature of ataxia. We have put together a comprehensive description of dysarthria in spinocerebellar...
        Read more